This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimonkevitz, R. Articles by Matsumura, M. Search for Related Content PubMed PubMed Citation Articles by Shimonkevitz, R. Articles by Matsumura, M.

 Previous Article  |  Next Article 

Infect. Immun., 04 1996, 1133-1139, Vol 64, No. 4
Copyright © 1996, American Society for Microbiology

Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1

R Shimonkevitz, E Boen, S Malmstrom, E Brown, JM Hurley, BL Kotzin and M Matsumura
Nexstar Pharmaceuticals, Inc., Lakewood Colorado, 80214, USA.

Murine monoclonal antibodies (MAbs) specific for toxic shock syndrome toxin 1 (TSST-1), a bacterial superantigen, showed the ability either to detect TSST-1 bound to histocompatibility locus antigen (HLA)-DR molecules or to inhibit TSST-1 binding to HLA-DR. A MAb capable of detecting DR-bound TSST-1 could also inhibit the toxin-induced activation of a T-cell receptor Vbeta15-expressing murine T-cell hybridoma. Alternatively, MAbs with specificity for the HLA-DR association site could present TSST-1 in vitro, stimulating CD4+ human T cells to proliferate. These functional activities correlated directly with with MAb specificity for HLA-DR versus T-cell receptor Vbeta interaction sites on TSST-1 as determined by reactivity with a panel of recombinant TSST-1 mutant molecules. Therefore, these MAbs discriminate the superantigen functional sites on the TSST-1 molecule and constitute reagents with the property of being potent modulators of the toxic activity of TSST-1.

This article has been cited by other articles:

• Pang, L. T. Y., Kum, W. W. S., Chow, A. W. (2000). Inhibition of Staphylococcal Enterotoxin B-Induced Lymphocyte Proliferation and Tumor Necrosis Factor Alpha Secretion by MAb5, an Anti-Toxic Shock Syndrome Toxin 1 Monoclonal Antibody. Infect. Immun. 68: 3261-3268 [Abstract] [Full Text]  
• Wahlsten, J. L., Mills, C. D., Ramakrishnan, S. (1998). Antitumor Response Elicited by a Superantigen- Transmembrane Sequence Fusion Protein Anchored onto Tumor Cells. J. Immunol. 161: 6761-6767 [Abstract] [Full Text]  
• Wahlsten, J. L., Ramakrishnan, S. (1998). Separation of Function Between the Domains of Toxic Shock Syndrome Toxin-1. J. Immunol. 160: 854-859 [Abstract] [Full Text]  
• Hamad, A. R. A., Marrack, P., Kappler, J. W. (1997). Transcytosis of Staphylococcal Superantigen Toxins. J. Exp. Med. 185: 1447-1454 [Abstract] [Full Text]